Robert A. Hamm has been named chief operating officer of Biogen Idec. Mr. Hamm has been executive vice president, Pharmaceutical Operations & Technology at the company since 2007. In his new role, he will add Global Business Operations to his responsibilities, effective immediately. Mr. Hamm replaces Hans Peter Hasler, who is leaving the company. “Bob has vast experience in virtually all aspects of our operations,” said Jim Mullen, BI’s chief executive officer. “His strong commercia...